Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

You might be able to join this study if you are between 18 and 75 years old and have been diagnosed with certain types of cancer, including breast, bowel, ovarian, pancreatic, or stomach cancer. It's important that your cancer hasn't spread to other parts of your body, and you must have finished your main chemotherapy treatment within the last three months (though hormone therapy is fine to continue).

To be eligible, you also need to be feeling well enough for daily activities, without too much difficulty, and your cancer must not have come back since you finished chemotherapy. You also need to be willing to sign a form saying you understand and agree to take part.

However, you won't be able to join if you have new cancer treatments planned soon (other than hormone therapy), have had certain types of immunotherapy, or if your doctor thinks you have heart or lung problems that would make exercise unsafe. Other reasons you might not be eligible include severe poor nutrition, unhealed severe wounds or fractures, or if you are already in another research study.

If you join this study, you will be randomly assigned to one of two groups. Both groups will participate in an adapted physical activity (APA) program. You will wear a smartwatch that tracks your physical activity from home. Researchers will monitor this information remotely. There might be a few hospital visits for assessments at the start and after three months to check your fatigue levels and overall health. The total time you'll be involved in the study will be around three months, which is when your fatigue levels will be measured again to see if the activity program has made a difference. There are no study medications involved.